Back to trial details

Intake questionnaire

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Applying to University of Utah - Huntsman Cancer Institute · Salt Lake City, Utah

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Solid Tumor?
3. Are you able to travel to Salt Lake City for study visits?